IP Library Granted Patent US 12,307,657
Granted Patent B2
US 12,307,657 · App. 17/348,840 · Granted May 20, 2025

System and method for quantifying the extent of disease from 2-D images

Inventor: Jiantao Pu (Sewickley, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
G06T7/0012G06N3/088G16H10/60G16H30/40G16H50/20G06T2207/30061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,307,657
App. No.
17/348,840
Granted
May 20, 2025
Kind
B2
Abstract

A disease assessment method includes using a machine learning system and 2-D image data to quantify an extent of disease in the patient, wherein the machine learning system has been previously trained using 3-D image data for each of a plurality of 3-D images obtained from a plurality of subjects, and 2-D image data for each of a plurality of 2-D images obtained from the plurality of subjects, wherein each of the 2-D images is associated with a corresponding one of the 3-D images and is captured at the same time as the corresponding one of the 3-D images or within a certain predetermined time frame of capturing the corresponding one of the 3-D images, and wherein a ground truth for the 2-D images comprises for each of the 3-D images a quantification of an extent of the predetermined disease based on the 3-D image data for the 3-D image.

Claims (47)

1. A method of training a predictive machine learning system for of lung disease, comprising:

receiving in a computer system (i) 3-D image data for each of a plurality of 3-D images obtained from a plurality of subjects, and (ii) 2-D image data for each of a plurality of 2-D images obtained from the plurality of subjects;

for each of the 3-D images, determining in the computer system a quantification of an extent of lung disease based on the 3-D image data for the 3-D image to create a ground truth for the 2-D images, wherein the quantification of the extent of lung disease comprises a percentage of lung low attenuation areas relative to total lung volume in the 3-D image based on a predetermined Hounsfield unit threshold; and

using each of the quantifications and the 2-D image data for each of the 2-D images to train the predictive machine learning system to be able to predict a quantitative extent of lung disease in a patient based on a received 2-D patient image.

2. The method according to claim 1 , wherein the using each of the quantifications and the 2-D image data for each of the 2-D images to train the predictive machine learning system comprises, for each of the 2-D images, labelling the 2-D image data of the 2-D image with the quantifications that was determined for the 3-D image that is associated with the 2-D image to create labeled 2-D image data, and using the labeled 2-D image data to train the predictive machine learning system.

3. The method according to claim 1 , wherein the predictive machine learning system is a deep learning system.

4. The method according to claim 3 , wherein the deep learning system is a deep neural network.

5. The method according to claim 4 , wherein the deep learning network is a convolution neural network.

6. The method according to claim 4 , wherein the deep learning network is a deep belief network.

7. The method according to claim 1 , wherein the 3-D images are each a CT image or an MRI image.

8. The method according to claim 1 , wherein each of the 3-D images is a CT image and each of the plurality of 2-D images is a 2-D CT scout radiograph.

9. The method according to claim 1 , wherein the received patient 2-D image is a 2-D x-ray image.

10. The method according to claim 1 , wherein each quantification comprises a percentage of lung voxels with a Hounsfield (HU) value below the predetermined Hounsfield unit threshold.

11. A computer program product, comprising a non-transitory computer usable medium having a computer readable program code embodied therein, the computer readable program code being adapted and configured to be executed to implement a method of training a predictive machine learning system for lung disease assessment according to claim 1 .

12. The method according to claim 1 , wherein each of the 2-D images is associated with but not derived form a corresponding one of the 3-D images and is captured by an imaging apparatus at the same time as the corresponding one of the 3-D images or within a certain predetermined time frame of capturing the corresponding one of the 3-D images.

13. The method according to claim 1 , wherein the predetermined Hounsfield unit threshold is a −950 Hounsfield unit threshold.

14. The method according to claim 1 , wherein the lung disease is emphysema.

15. A lung disease assessment method, comprising:

receiving 2-D patient image data representing a 2-D image of a patient, and

providing the 2-D patient image data to a predictive machine learning system and using the predictive machine learning system and the 2-D patient image data to quantify an extent of lung disease in the patient, wherein the predictive machine learning system has been previously trained using: (i) 3-D image data for each of a plurality of 3-D images obtained from a plurality of subjects, (ii) 2-D image data for each of a plurality of 2-D images obtained from the plurality of subjects; and (iii) a ground truth for the 2-D images comprising for each of the 3-D images a quantification of an extent of lung disease based on the 3-D image data for the 3-D image, wherein the quantification of the extent of lung disease comp percentage of lung low attenuation areas relative to total lung volume in the 3-D image based on a predetermined Hounsfield unit threshold.

16. The method according to claim 15 , wherein the predictive machine learning system is a deep learning system.

17. The method according to claim 16 , wherein the deep learning system is a deep neural network.

18. The method according to claim 17 , wherein the deep learning network is a convolution neural network.

19. The method according to claim 17 , wherein the deep learning network is a deep belief network.

20. The method according to claim 15 , wherein the 3-D images are each a CT image or an MRI image.

21. The method according to claim 15 , wherein each of the 3-D images is a CT image and each of the plurality of 2-D images is a 2-D CT scout radiograph.

22. The method according to claim 15 , wherein the 2-D image of the patient is a 2-D x-ray image.

23. The method according to claim 15 , wherein each quantification comprises a percentage of lung voxels with a Hounsfield (HU) value below the predetermined Hounsfield unit threshold.

24. A computer program product, comprising a non-transitory computer usable medium having a computer readable program code embodied therein, the computer readable program code being adapted to be executed to implement a lung disease assessment method as recited in claim 15 .

25. The method according to claim 15 , wherein each of the 2-D images is associated with but not derived form a corresponding one of the 3-D images and is captured by an imaging apparatus at the same time as the corresponding one of the 3-D images or within a certain predetermined time frame of capturing the corresponding one of the 3-D images.

26. The method according to claim 15 , wherein the predetermined Hounsfield unit threshold is a −950 Hounsfield unit threshold.

27. The method according to claim 15 , wherein the lung disease is emphysema.

28. A lung disease assessment system, comprising:

a computing device implementing a predictive machine learning system, the computing device having a processor apparatus structured and configured to:

receive 2-D patient image data representing a 2-D image of a patient; and

use the predictive machine learning system and the 2-D patient image data to quantify an extent of lung disease in the patient, wherein the predictive machine learning system has been previously trained using (1) 3-D image data for each of a plurality of 3-D images obtained from a plurality of subjects, (ii) 2-D image data for each of a plurality of 2-D images obtained from the plurality of subjects, and (iii) a ground truth for the 2-D images comprising for each of the 3-D images a quantification of an extent of lung disease based on the 3-D image data for the 3-D image, wherein the qualification of the extent of lung disease comprises a percentage of lung low attenuation areas relative to total lung volume in the 3-D image based on a predetermined Hounsfield unit threshold.

29. The system according to claim 28 , wherein the predictive machine learning system is a deep learning system.

30. The system according to claim 29 , wherein the deep learning system is a deep neural network.

31. The system according to claim 30 , wherein the deep learning network is a convolution neural network.

32. The system according to claim 30 , wherein the deep learning network is a deep belief network.

33. The system according to claim 28 , wherein the 3-D images are each a CT image or an MRI image.

34. The system according to claim 28 , wherein each of the 3-D images is a CT image and each of the plurality of 2-D images is a 2-D CT scout radiograph.

35. The system according to claim 28 , wherein the 2-D image of the patient is a 2-D x-ray image.

36. The system according to claim 28 , wherein each quantification comprises a percentage of lung voxels with a Hounsfield (HU) value below the predetermined Hounsfield unit threshold.

37. The system according to claim 28 , wherein each of the 2-D images is associated with but not derived form a corresponding one of the 3-D images and is captured by an imaging apparatus at the same time as the corresponding one of the 3-D images or within a certain predetermined time frame of capturing the corresponding one of the 3-D images.

38. The system according to claim 28 , wherein the predetermined Hounsfield unit threshold is a −950 Hounsfield unit threshold.

39. The system according to claim 28 , wherein the lung disease is emphysema.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 5, 2023
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065776/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2021
From: PU, JIANTAO
To: UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 056619/0137 →
Continuity (2)
Provisional Application 63078512 · Sep 15, 2020
Related Publication 20220084193A1 · Mar 17, 2022
References Cited (11)
US 20150238270A1 · Raffy · 2015 [cited by examiner]
US 20180061058A1 · Xu · 2018 [cited by examiner]
US 20190295709A1 · Chabin · 2019 [cited by examiner]
US 20200380680A1 · Aoyagi · 2020 [cited by examiner]
US 20210192279A1 · Laaksonen · 2021 [cited by examiner]
US 20210398654A1 · Chaganti · 2021 [cited by examiner]
US 20220157048A1 · Ting · 2022 [cited by examiner]
US 20220384035A1 · Shi · 2022 [cited by examiner]
Filippo Arcadu, Fethallah Benmansour, Andreas Maunz, John Michon, Zdenka Haskova, Dana McClintock, Anthony P. Adamis, Jeffrey R. Willis, Marco Prunotto; Deep Learning Predicts OCT Measures of Diabetic Macular Thickening… [cited by applicant]
Varadarajan, A.V., Bavishi, P., Ruamviboonsuk, P. et al. Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning. Nat Commun 11, 130 (2020). https://doi.… [cited by applicant]
Pu, J., Sechrist, J., Meng, X., Leader, J.K. and Sciurba, F. (2021), A pilot study: quantify lung vol. and emphysema extent directly from 2-D scout images. Medical Physics. Accepted Author Manuscript. https://doi.org/10… [cited by applicant]